Shiting Li Selected Research

Hemifacial Spasm

5/2022	New Technology: Compound Abnormal Muscle Response During Microvascular Decompression for Hemifacial Spasm.
3/2022	A New Application of Gelatin Sponge in the Treatment of Hemifacial Spasm by Microvascular Decompression: A Technical Note.
1/2022	Latency of Spread: An Important Clinical Indicator Reflecting the Complexity Level of Offending Vessels in Patients with Typical Hemifacial Spasm.
3/2020	Hypertension and Diabetes Are Associated With Clinical Characteristics in Patients Undergoing Microvascular Decompression for Hemifacial Spasm.
1/2020	Evaluation of pre-operative neuroimaging characteristics in patients with primary hemifacial spasm as a prognostic factor of microvascular decompression.
10/2019	Outcomes and Safety of Overlapping Surgery in Patients Undergoing Microvascular Decompression for Hemifacial Spasm and Trigeminal Neuralgia.
7/2019	Long-term Outcomes of Microvascular Decompression in the Treatment of Hemifacial Spasm Based on Different Offending Vessels.
7/2019	Treatment of Venous Hemorrhage Between Vestibulocochlear Nerve and Hypertrophic Flocculus During Microvascular Decompression Procedure for Hemifacial Spasm.
10/2018	Involved Small Arteries in Patients Who Underwent Microvascular Decompression for Hemifacial Spasm.
2/2018	Efficacy of Biomedical Glue Sling Technique Versus Traditional Technique for Microvascular Decompression for Hemifacial Spasm with Refractory Hypertension.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiting Li Research Topics

Disease

21	Hemifacial Spasm 05/2022 - 12/2010
16	Neoplasms (Cancer) 01/2022 - 01/2011
13	Trigeminal Neuralgia (Tic Douloureux) 07/2021 - 05/2011
7	Glioma (Gliomas) 01/2020 - 01/2011
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2022 - 01/2017
4	Pain (Aches) 08/2019 - 05/2011
3	Bell Palsy (Bell's Palsy) 10/2022 - 03/2013
3	Brain Ischemia (Cerebral Ischemia) 10/2022 - 05/2013
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 04/2014
2	Ischemic Stroke 10/2022 - 05/2019
2	Wounds and Injuries (Trauma) 02/2022 - 04/2011
2	Crush Injuries 12/2020 - 10/2020
2	Hypertension (High Blood Pressure) 03/2020 - 02/2018
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 03/2013
2	Infarction (Infarctions) 01/2017 - 05/2013
2	Cerebral Infarction 01/2017 - 01/2011
2	Oculomotor Nerve Injuries 11/2012 - 04/2011
1	Synkinesis 10/2022
1	Neuroinflammatory Diseases 10/2022
1	Facial Paralysis (Facial Palsy) 03/2022
1	Hearing Loss (Hearing Impairment) 03/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2021
1	Craniopharyngioma (Craniopharyngiomas) 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Infections 01/2021
1	Cardiotoxicity 10/2020
1	Cardiomyopathies (Cardiomyopathy) 10/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2020
1	Cluster Headache (Cluster Headaches) 12/2019
1	Hemorrhage 07/2019
1	Torticollis (Wryneck) 12/2017
1	Atherosclerosis 09/2017
1	Stroke (Strokes) 01/2017
1	Hypesthesia (Numbness) 01/2017
1	Plasmacytoma 10/2016

Drug/Important Bio-Agent (IBA)

5	Biological ProductsIBA 11/2021 - 01/2011
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2014
3	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 05/2019
3	Pharmaceutical PreparationsIBA 11/2021 - 12/2019
3	Long Noncoding RNAIBA 10/2020 - 10/2016
3	Netrin-1IBA 05/2019 - 01/2017
3	Messenger RNA (mRNA)IBA 02/2017 - 05/2013
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 02/2014
2	Oxygen (Dioxygen)IBA 10/2022 - 05/2019
2	GelatinIBA 03/2022 - 07/2019
2	Indicators and Reagents (Reagents)IBA 01/2022 - 02/2014
2	Therapeutic UsesIBA 10/2020 - 09/2014
2	Pain-FreeIBA 08/2019 - 04/2016
2	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 07/2019 - 04/2016
2	SolutionsIBA 07/2019 - 12/2010
2	Nerve Growth Factors (Neurotrophins)IBA 01/2019 - 05/2013
2	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2018 - 01/2011
2	MicroRNAs (MicroRNA)IBA 02/2017 - 01/2015
1	Testosterone (Sustanon)FDA Link 10/2022
1	Gonadal HormonesIBA 10/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2022
1	ginkgetinIBA 10/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 03/2022
1	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (FCCP)IBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 11/2021
1	AntioxidantsIBA 01/2021
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	apatinibIBA 01/2021
1	CateninsIBA 12/2020
1	Dacarbazine (DIC)FDA LinkGeneric 10/2020
1	Sirtuin 2IBA 10/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020
1	deoxyguanosine kinaseIBA 10/2020
1	Competitive Endogenous RNAIBA 10/2020
1	Antisense RNA (Anti-Sense RNA)IBA 10/2020
1	Annexin A1IBA 10/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Uric Acid (Urate)IBA 09/2019
1	LigandsIBA 01/2019
1	neuroligin 3IBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	CalciumIBA 05/2017
1	MagnesiumIBA 05/2017
1	3' Untranslated Regions (3' UTR)IBA 02/2017

Therapy/Procedure

33	Microvascular Decompression Surgery 05/2022 - 12/2010
6	Decompression 03/2022 - 05/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2022 - 05/2013
2	Therapeutics 11/2021 - 10/2018
2	Drug Therapy (Chemotherapy) 10/2020 - 01/2011
2	Radiotherapy 01/2019 - 10/2017
2	Electrocoagulation (Electrocautery) 01/2017 - 10/2016
2	Surgical Instruments (Clip) 04/2016 - 11/2012
1	Photochemotherapy (Photodynamic Therapy) 11/2021
1	Neoadjuvant Therapy 01/2021
1	Ligation 12/2019
1	Overlapping Surgery 10/2019
1	Operative Surgical Procedures 07/2019
1	Denervation 12/2017
1	Toothbrushing 01/2017